December 14, 2018 Cell Analysis Tools PR/Corporate

Fluidigm Announces Closing of Public Offering of 9,372,500 Shares of Common Stock Including Full Exercise of Option to Purchase Additional Shares

PDF Version SOUTH SAN FRANCISCO, Calif., Dec. 14, 2018 (GLOBE NEWSWIRE) — Fluidigm Corporation (NASDAQ: FLDM), a leader in mass cytometry and microfluidics technologies, today announced the closing of its previously announced underwritten public offering of 9,372,500 shares of its common stock. The stock was sold at a price to the public of $6.75 per share, for aggregate gross proceeds of... Read more

December 13, 2018 Lab Furniture PR/Corporate

Kewaunee Announces Resignation of William A. Shumaker as Chairman of the Board of Directors

Exchange: NASDAQ (KEQU) Contact: Thomas D. Hull III (704) 871-3290 STATESVILLE, N.C. December 13, 2018 – PRNewswire / Kewaunee Scientific Corporation (NASDAQ: KEQU) announced today the resignation of William A. Shumaker as Chairman of the Board of Directors and as a Director of the Company, effective January 31, 2019. Mr. Shumaker cited personal reasons as... Read more

December 11, 2018 Cell Analysis Tools PR/Corporate

Fluidigm Announces Pricing of Public Offering of 8,150,000 Shares of Common Stock

PDF Version SOUTH SAN FRANCISCO, Calif., Dec. 11, 2018 (GLOBE NEWSWIRE) — Fluidigm Corporation (NASDAQ: FLDM), a leader in mass cytometry and microfluidics technologies, today announced the pricing of an underwritten public offering of 8,150,000 shares of its common stock at a price to the public of $6.75 per share for aggregate gross proceeds of approximately $55 million. Fluidigm has granted to the underwriters... Read more

December 11, 2018 Cell Analysis Tools PR/Corporate

Fluidigm Announces Commencement of Public Offering of Common Stock

PDF Version SOUTH SAN FRANCISCO, Calif., Dec. 11, 2018 (GLOBE NEWSWIRE) — Fluidigm Corporation (NASDAQ: FLDM), a leader in mass cytometry and microfluidics technologies, today announced that it intends to offer and sell, subject to market and other conditions, shares of its common stock in an underwritten public offering pursuant to Fluidigm’s existing shelf registration statement. In connection with... Read more

December 10, 2018 PR/Corporate

Xylem Named to The JUST 100 America’s Best Corporate Citizens List

Xylem recognized in Leadership Category RYE BROOK, N.Y.–(BUSINESS WIRE)–Dec. 10, 2018– Global water technology company, Xylem (NYSE:XYL), has been included on Forbes2018 “JUST 100” list, a ranking of 100 companies that have made a significant economic and social impact through their core business strategy. Xylem was recognized in the category of Company Leadership and Shareholders,... Read more

December 10, 2018 Lab Top-10 PR/Corporate

PerkinElmer Appoints President & Chief Operating Officer

Promotes Prahlad Singh to lead newly created role WALTHAM, Mass.–(BUSINESS WIRE)–Dec. 10, 2018– PerkinElmer, Inc. (NYSE:PKI), a global leader committed to innovating for a healthier world, today announced that its board of directors has named Prahlad Singh president and chief operating officer, effective January 1, 2019. In his expanded position, Dr. Singh will have responsibility... Read more

December 10, 2018 PR/Corporate

New member proposed for election to Roche Board of Directors

Basel, 10 December 2018 New member proposed for election to Roche Board of Directors Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that at its December meeting the Board of Directors (BoD) of Roche Holding Ltd decided on first proposals for approval by the Annual General Meeting (AGM), scheduled for 5 March 2019. The BoD... Read more

December 10, 2018 PR/Corporate

Changes to the Roche Corporate Executive Committee

Basel, 10 December 2018 Changes to the Roche Corporate Executive Committee Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that Daniel O’Day, CEO Roche Pharmaceuticals and member of the Corporate Executive Committee, will be stepping down from his role as of 31 December 2018. Until the end of February 2019 and prior to assuming new... Read more